全球化学品在线数据库
| CAS 登录号 | 产品名称 | 分子式 |
|---|---|---|
| 1355631-24-1 | 5-Chloro-4-[(3,4-dichlorophenoxy)methyl]-2-fluoro-N-(methylsulfonyl)benzamide | C15H11Cl3FNO4S |
| 1355729-38-2 | Zinc difluoromethanesulfinate;Baran reagent | Zn(CHF2O2S)2 |
| 1355990-11-2 | [[[(1S)-1-(3-Butyn-1-yl)hexyl]oxy]methyl]benzene | C17H24O |
| 1356019-51-6 | Bis valacyclovir;2-[[2-[[[9-[2-[(2S)-2-amino-3-methylbutanoyl]oxyethoxymethyl]-6-oxo-1H-purin-2-yl]amino]methylamino]-6-oxo-1H-purin-9-yl]methoxy]ethyl (2S)-2-amino-3-methylbutanoate | C27H40N12O8 |
| 1356020-01-3 | (4S)-2-[[[(2R)-2-Amino-2-(4-hydroxyphenyl)acetyl]amino]methyl]-5,5-dimethyl-4-thiazolidinecarboxylic Acid | C15H21N3O4S |
| 1356066-65-3 | (6-Cyano-5-fluoropyridin-3-yl)boronic acid pinacol ester;3-Fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)picolinonitrile | C12H14BFN2O2 |
| 1356113-40-0 | 2-Chloro-5-fluoro-4-(trifluoromethyl)pyridine | C6H2ClF4N |
| 1356400-78-6 | 2-(Dimethylamino)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde | C15H22BNO3 |
| 1356565-46-2 | Imatinib Impurity 8;N-(2-methyl-5-(4-((4-methylpiperazin-1-yl)methyl)benzamido)phenyl)-4-((4-methylpiperazin-1-yl)methyl)-N-(4-(pyridin-3-yl)pyrimidin-2-yl)benzamide | C42H47N9O2 |
| 1356837-89-2 | Perindopril EP Impurity E;Perindoprilat Isopropyl Ester | C20H34N2O5 |
| 1356841-89-8 | Tacrolimus-<sup>13</sup>C;(3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-Hexadecahydro-5,19-dihydroxy-3-[(1E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propenyl-3-<sup>13</sup>C-d<sub>2</sub>)-15,19-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone | C44H67D2NO12 |
| 1356906-17-6 | 2-[2-[2-[2-(4-Dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethoxy]ethoxy]ethanol | C25H33N3O4S |
| 1356929-58-2 | Perindopril-d4;(2S,3aS,7aS)-1-[(2S)-2,3,3,3-tetradeuterio-2-[[(2S)-1-ethoxy-1-oxopentan-2-yl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid | C19D4H28N2O5 |
| 1356933-89-5 | L-(+)-Ergothioneine-d3;5-[(2S)-2-carboxy-2-[dimethyl(trideuteriomethyl)azaniumyl]ethyl]-1H-imidazole-2-thiolate | C9H15N3O2S |
| 1356962-20-3 | N-[4-(4-Amino-1-piperidinyl)-2-methoxyphenyl]-5-chloro-4-(1H-indol-3-yl)-2-pyrimidinamine | C24H25ClN6O |
| 1356963-01-3 | 2-Methoxy-5-methyl-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)aniline | C18H30N4O |
| 1357072-61-7 | 3-[(2-Methyl-2H-indazol-5-yl)thio]-6-(1-methyl-1H-pyrazol-4-yl)-1,2,4-triazolo[4,3-b]pyridazine;c-Met inhibitor | C17H14N8S |
| 1357078-03-5 | B-(2-Oxo-2H-1-benzopyran-7-yl)boronic Acid | C9H7BO4 |
| 1357160-72-5 | URB 937 | C20H22N2O4 |
| 1357171-62-0 | N-([1,1'-Biphenyl]-4-ylmethyl)-6-phenyl-3-(2-pyridinyl)-1,2,4-triazin-5-amine;ML 228 | C27H21N5 |
| 1357289-08-7 | 1-(2,2-Dimethoxyethyl)-1,4-dihydro-4-oxo-3-(phenylmethoxy)-2,5-pyridinedicarboxylic acid 2,5-dimethyl ester | C20H23NO8 |
| 1357289-29-2 | Dolutegravir Impurity B;Dolutegravir RR isomer;(3R,7R)-N-[(2,4-difluorophenyl)methyl]-11-hydroxy-7-methyl-9,12-dioxo-4-oxa-1,8-diazatricyclo[8.4.0.03,8]tetradeca-10,13-diene-13-carboxamide | C20H19F2N3O5 |
| 1357302-64-7 | 4'-((1R,2S)-2-Aminocyclopropyl)biphenyl-3-ol | C15H15NO |
| 1357351-29-1 | 6-Hydroxy-2-(hydroxymethyl)-2-methyl-2H-naphtho[1,2-b]pyran-5-carboxylic acid methyl ester | C17H16O5 |
| 1357353-58-2 | 2-Methyl-4-pyridinemethanamine hydrochloride (1:2) | C7H10N2.2(HCl) |
| 1357389-11-7 | (2E)-N-(2-Amino-4-fluorophenyl)-3-[1-(3-phenyl-2-propen-1-yl)-1H-pyrazol-4-yl]-2-propenamide;RGFP 966 | C21H19FN4O |
| 1357470-29-1 | 8-Cyclopentyl-7,8-dihydro-2-[[4-(4-methyl-1-piperazinyl)phenyl]amino]-7-oxo-pyrido[2,3-d]pyrimidine-6-carbonitrile;ON 123300 | C24H27N7O |
| 1357471-44-3 | Methanol, compd. with N1-1-naphthalenyl-1,2-ethanediamine, hydrochloride (1:1:2) | C12H14N2.CH4O.2(HCl) |
| 1357503-31-1 | 1-(Azidosulfonyl)-1H-imidazol-3-ium tetrafluoroborate;N-diazo-1H-imidazol-3-ium-3-sulfonamide tetrafluoroborate | C3H4BF4N5O2S |
| 1357572-66-7 | 9-bromo-7H-benzo[c]carbazole | C16H10BrN |
| 1357572-67-8 | 9-bromo-7-phenyl-7H-benzo[c]carbazole | C22H14BrN |
| 1357600-60-2 | (S)-Tert-butyl 4-amino-3,3-dimethylpiperidine-1-carboxylate;tert-butyl (4S)-4-amino-3,3-dimethylpiperidine-1-carboxylate | C12H24N2O2 |
| 1357600-61-3 | (R)-Tert-butyl 4-amino-3,3-dimethylpiperidine-1-carboxylate;tert-butyl (4R)-4-amino-3,3-dimethylpiperidine-1-carboxylate | C12H24N2O2 |
| 1357634-60-6 | 9-[2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-9H-carbazole | C24H24BNO2 |
| 1357910-26-9 | Isoforsythiaside | C29H36O15 |
| 1357931-55-5 | 3-(6,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxybenzenesulfonic acid | C17H20N4O5S |
| 1357942-79-0 | 4-Amino-2-fluoro-5-methylbenzonitrile | C8H7FN2 |
| 1357946-55-4 | 6-Bromo-3-iodo-1H-pyrazolo[3,4-b]pyridine | C6H3BrIN3 |
| 1357946-70-3 | 3-Bromo-6-chloro-1H-pyrazolo[3,4-b]pyridine | C6H3BrClN3 |
| 1357947-08-0 | 5-Bromo-3-iodo-1H-pyrazolo[3,4-c]pyridine | C6H3BrIN3 |
| 1358581-37-9 | Methyl 1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-alpha-D-glucopyranoside | C25H27FO6S |
| 1358679-89-6 | 2-(3-Piperidinylidene)acetic acid ethyl ester | C9H15NO2 |
| 1359164-11-6 | 2-Fluoro-4'-[[4-(4-pyridinylmethyl)-1-piperazinyl]methyl]-alpha,alpha-bis(trifluoromethyl)-[1,1'-biphenyl]-4-methanol | C26H24F7N3O |
| 1359655-87-0 | 6-Fluoroimidazo[1,2-a]pyridine-3-carboxylic acid ethyl ester | C10H9FN2O2 |
| 1359658-29-9 | (2S)-2-Cyano-1-piperazinecarboxylic acid 1,1-dimethylethyl ester | C10H17N3O2 |
| 1359658-38-0 | (3R)-4-(5-Carboxy-2-pyridinyl)-3-methyl-1-piperazinecarboxylic acid 1-(1,1-dimethylethyl) ester | C16H23N3O4 |
| 1359658-44-8 | (2R)-2-Cyano-1-piperazinecarboxylic acid 1,1-dimethylethyl ester | C10H17N3O2 |
| 1359658-57-3 | (2S)-2-Morpholinecarbonitrile | C5H8N2O |
| 1359704-27-0 | 2C-P Hydrochloride | C13H22ClNO2 |
| 1359704-84-9 | 2-Oxo-6-azaspiro[3.5]nonane-6-carboxylic acid 1,1-dimethylethyl ester | C13H21NO3 |